STOP TB Partnership says the fight against tuberculosis (TB) could be set back by more than five years due to the coronavirus pandemic, risking an additional 1.4 million TB deaths and 6.3 million infections by 2025, report says.
A new modeling study released by @StopTB, @imperialcollege, @AvenirHealth, @JohnsHopkins, shows an additional 6.3M people will develop TB by 2025 due to the impact of #COVID19 👉https://t.co/FpZvlWqiKL pic.twitter.com/I6V7s3SwNd
— UNOPS (@UNOPS) May 7, 2020
The Stop TB Partnership is a Geneva-based international body leading the global fight against the respiratory illness that infects more than 10 million people annually.
Data from three countries with high TB prevalence, Kenya, India, and Ukraine, was used for the new report.
Kenya is among the countries with the highest TB burden in the world with an estimated 558 people in every 100,000 infected.
The study says coronavirus lockdowns affecting poor people who cannot practice social distancing in their homes mean a higher risk of TB transmission while restricted movements disrupt treatment.
The transformation of TB hospitals and services for coronavirus testing and treatment has also taken a heavy toll.
In extreme cases where a lockdown lasts up to three months, the study estimates that it might take up to 10 months to restore TB services to normal levels.
“Addressing the disease will take far longer. In fact, it takes several years for the elevated TB burden to come back to pre-lockdown levels. The more severe the lockdown, the more severe the long-term impact,” says an associate professor in mathematical epidemiology at Imperial College London, Nimalan Arinaminpathy.
Other unintended effects of the COVID-19 outbreak include the stigma that TB patients might face, said Cheri Vincent, chief of the TB division at USAID.
“Here you have people who have similar symptoms to those of the coronavirus, and some would be even afraid of approaching health facilities because they would face the stigma of being identified as having COVID-19,” she said.
She also expressed concern that COVID-19 could have a devastating effect on TB patients as both diseases attack the respiratory system.
Researchers behind the study also lamented the sudden capacity given to research and development for a COVID-19 vaccine compared to that for TB over the years.
“We are looking with amazement at how COVID-19 has been around some 128 days but already has about 100 candidate vaccines,” said Stop TB executive director Lucica Ditiu.
“The new agenda is vaccines and treatment for COVID-19. Nobody is talking about vaccines for HIV, malaria, or TB.”
Source: VON
